About: http://data.cimple.eu/news-article/07e298e1daf6343ea850e48f79f77d191179694963aa73e05f247d23

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/07e298e1daf6343ea850e48f79f77d191179694963aa73e05f247d23 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	US pharmaceutical firm Moderna said Thursday it expects to increase global production of its cutting-edge Covid vaccine to up to three billion doses in 2022. The company said in a statement that it would make new funding commitments to increase supply at its manufacturing facilities in Europe and the United States. The investments will double the manufacturing of drug substance at its Swiss partner Lonza and more than double output by Rovi in Spain. Production at Moderna's US facilities would increase by 50 percent. Reaching the three billion mark will depend on the mix of its mRNA vaccine and potentially lower doses of Moderna's pediatric vaccine and variant booster shots, the company said. The company also raised its supply forecast for this year to between 800 million and one billion doses. The announcement comes as the spread of virus variants in countries like India have raised concerns about the world's ability to overcome the pandemic. "As we follow the rapid spread of SARS-CoV-2 variants of concern, we believe that there will continue to be significant need for our mRNA COVID-19 vaccine and our variant booster candidates into 2022 and 2023," chief executive Stephane Bancel said in the statement. The messenger mRNA vaccines hack into human cells and effectively turns them into vaccine-making factories. mch-lth/spm
schema:headline	Moderna eyes three billion Covid vaccine doses in 2022
schema:mentions	Pediatrics RNA vaccine Switzerland Spain Messenger RNA European Union Pandemic Virus India Coronavirus disease Vaccine United States Severe acute respiratory syndrome coronavirus 2 The Messenger (2009 film) TiVo Corporation Lonza Group
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-04-29 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software